Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evoke Pharma Inc (NASDAQ:EVOK)

3.60
Delayed Data
As of 1:07pm ET
 -0.12 / -3.23%
Today’s Change
1.35
Today|||52-Week Range
4.55
+78.22%
Year-to-Date
New Strong Sell Stocks for October 17th
10:30am / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close3.72
Today’s open3.75
Day’s range3.54 - 3.80
Volume143,493
Average volume (3 months)104,587
Market cap$57.2M
Dividend yield--
Data as of 1:07pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)+38.50%
Earnings growth (this year)+24.78%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book12.13

Competitors

 Today’s
change
Today’s
% change
BVXVBiondVax Pharmaceuti...+0.33+4.40%
ISRIsoRay Inc-0.00-0.62%
IBIOIbio Inc+0.01+3.17%
CYANCyanotech Corp+0.30+6.38%
Data as of 1:06pm ET, 10/17/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$10.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class I Director
David A. Gonyer
Chief Medical Officer
Marilyn R. Carlson
Corporate headquarters
Solana Beach, California

Forecasts